Clinical Trial Update: Influence of Aromatase Inhibition on Hepatic- and Cardiac Function in Severe Obese Men [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing how aromatase inhibition affects hepatic and cardiac function in severely obese men has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: University Hospital, Ghent | Conditions: Obesity | Phase 4 | Status: COMPLETED